Janus considers the HIV pandemic--harnessing recent advances to enhance AIDS prevention.
Open Access
- 1 January 1997
- journal article
- Published by American Public Health Association in American Journal of Public Health
- Vol. 87 (1), 10-12
- https://doi.org/10.2105/ajph.87.1.10
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic MillimeterNew England Journal of Medicine, 1996
- Therapy for Human Immunodeficiency Virus Infection — What Have We Learned?New England Journal of Medicine, 1996
- The Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic MillimeterNew England Journal of Medicine, 1996
- Prognostic Value of Plasma Human Immunodeficiency Virus Type 1 (HIV-l) RNA Levels in Patients with Advanced HIV-l Disease and with Little or No Prior Zidovudine TherapyThe Journal of Infectious Diseases, 1996
- Overview: Individual And Population Approaches To The Epidemiology And Prevention Of Sexually Transmitted Diseases And Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 1996
- AIDS in 1996. Much accomplished, much to doJAMA, 1996
- Nevirapine, Zidovudine, and Didanosine Compared with Zidovudine and Didanosine in Patients with HIV-1 InfectionAnnals of Internal Medicine, 1996
- Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in PlasmaScience, 1996
- Treatment of Human Immunodeficiency Virus Infection with Saquinavir, Zidovudine, and ZalcitabineNew England Journal of Medicine, 1996
- Changes in Plasma HIV-1 RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDSNew England Journal of Medicine, 1996